EKF’s new Altair™240 Clinical Chemistry Analyzer Revealed to UK Audience at IBMS 2015
The new Altair™ 240 fully automated analyzer designed with Stanbio chemistry products in mind
The new Altair™ 240 fully automated analyzer designed with Stanbio chemistry products in mind
Through advanced genetic algorithms and supercomputing, scientists have discovered how genetic diseases such as cancer systematically attack the networks controlling human cells, according to a pair of papers published back-to-back in CELL.
90% chance of anemia in ICU patients after 3 days - diagnostic blood sampling a key factor
New whitepaper demonstrates how customizable, medically focused array designs complement NGS for clinical genetics research
A first-in-man clinical study is planned to start in 2016, with top line results expected end 2017
Professor Paul Cockwell addresses the delegation at the 7th International Binding Site Symposium
ImmunoXpert™ blood test uses novel technology to accurately distinguish between bacterial and viral infections
Early identification of the disease will allow specific and extremely effective therapies for the treatment of patients
System from Quest Diagnostics' products business is first FDA-cleared Herpes Simplex Virus 1 and 2 test that uses genital swab or cerebrospinal fluid (CSF) specimen collection
Reprogramming microbes for innovative therapies
Unique System Proven to Improve Laboratory Workflow and Productivity for Infectious Disease
The CEO of EKF Molecular discusses the use of PointMan technology in recent clinical studies